Close
  • Skip to primary navigation
  • Skip to main content
  • Skip to footer

Altitude Accelerator

Scaling Innovation to New Heights (Formerly RIC Centre)

Listen to our latest podcast episode with Amit Chauhan, CEO of JobAdX on Startups Transformed!

Altitude Accelerator
  • About
    • About Altitude Accelerator
    • Team
    • Success Stories
    • Community Partners
  • Services
  • Blog
  • Altitude Accelerator Incubator Program
  • Events
    • IoT Tech Showcase 2019
    • Angel First Look Investor Meeting
  • Resources
    • Software Development for Startups: An In-Depth Guide
    • Opportunities
    • Tech Jobs
  • Job Board
  • Register for support
  • Get In Touch

Follow RIC Centre

Search This Site

Français

  • About
    • Our Team
    • Our Advisors
    • Success Stories
    • Rebrand to Altitude Accelerator
    • Community Partners
    • Contact Us
  • Services
  • Programs
    • RevUp
    • Altitude Accelerator Incubator
    • Investor Readiness
    • Altitude Accelerator: Cleantech
  • Events
  • Resources
    • Startups Transformed Podcast
    • Blog
    • Startup Opportunities
    • Client Resources
    • Software Development Guide
JOIN US
You are here: Home / Blog / Startup H3 Biomedicine uses patient genomes to develop drugs

Startup H3 Biomedicine uses patient genomes to develop drugs

Tags: life science, Technology

August 1, 2012 RICCentre

Startup H3 Biomedicine uses patient genomes to develop drugs, Altitude AcceleratorBy: Fatema Fatakdawala
Adapted from an article in Technology Review by MIT

So what does personalized medicine really mean? In essence, instead of developing drugs and looking for patients that could be cured with them, we analyze patients and make drugs based on their individual needs. As you can tell, from a marketing perspective, its a dream come true! Massachusetts-based startup, H3 Biomedicines, is implementing this plan of action by developing drugs for cancer patients based on the genetic and molecular signatures of the patient’s genome. In this way, they can target specific patient populations with superior medicines.   

H3 has all the information they need available; the genome databanks of tumors from thousands of patients compiled by organizations such as The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium. By searching for cancer mutations in 3000 patient tumors, they narrowed down to rare anomalies shared by 1 – 10% of cancers in patient populations. Startup H3 Biomedicine uses patient genomes to develop drugs, Altitude Accelerator

“The lesson may be that cancer drugs will not play into the pharmaceutical industry’s previous search for blockbuster drugs. There’s not some big novel cancer gene that no one had known before, one that induces 50 percent of breast cancer and 65 percent of lung cancer. That’s not what the data tells us,” says Markus Warmuth, CEO of the company.

Warmuth believes that with today’s decreasing DNA sequencing costs, H3 can take advantage and solve the patient problem. Rather than enrolling patients in a clinical trial and then determining whether they carry the right mutation targeted by a machine-generated drug candidate, patients could have their tumor’s genome sequenced and then share the information in a database available to pharmaceutical companies. “Then you could more proactively approach patients in the future, and ask them if they are willing to become part of a clinical trial as drugs are being developed for particular genetic [changes].”

Read more on Technology Review

Fatema joins the RIC team as the Communications Officer responsible for marketing, social media, event and web management. She is a graduate student pursuing her final year in the Master of Biotechnology program at the University of Toronto Mississauga.

Startup H3 Biomedicine uses patient genomes to develop drugs, Altitude AcceleratorThe RIC blog is designed as a showcase for entrepreneurs and innovation. Our guest bloggers provide a wealth of information based on their personal experiences. Visit Altitude Accelerator for more information on how RIC can accelerate your ideas to market.

Footer

Altitude Accelerator is located at

6 George Street South,
Brampton, ON
L6Y 1P1

Stay Updated

Join our mailing list to get our monthly update on Canadian innovation and tech, as well as notifications about Altitude Accelerator workshops and seminars!

Subscribe
  • Job Board
  • Our Team
  • Contact Us
  • Monthly Digest
  • Français
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Trilliumlogo

Copyright © 2022 Altitude Accelerator